Denosumab: a review of its use in postmenopausal women with osteoporosis.
about
Osteoporosis: a discussion on the past 5 years.Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosisOsteoporosis in chronic obstructive pulmonary diseaseA Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women.Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United StatesReduced bone resorption by intake of dietary vitamin D and K from tailor-made Atlantic salmon: A randomized intervention trial.Adrenomedullin inhibits osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand-induced nuclear factor-κB activation in glucocorticoid-induced osteoporosis.Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis.Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.Liuwei Dihuang Pill () treats postmenopausal osteoporosis with Shen (Kidney) yin deficiency via Janus kinase/signal transducer and activator of transcription signal pathway by up-regulating cardiotrophin-like cytokine factor 1 expression.Tanshinone‑IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF‑κB signaling pathway.Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study.
P2860
Q33700265-BC3E08A6-CAB5-4A6C-840B-985E970EAAE0Q35092602-85D2853D-03A4-4E4E-AF14-5802C23D6F2FQ35173349-750E6CEF-FC77-400D-AD75-8ADA460084BDQ35248988-DE52D8F3-DBEE-4A98-A1F1-9711A85BC530Q37670574-EE841C3E-32A5-4655-8492-0C1C221421A2Q37688337-F2DBC6B4-AF2D-40FA-92EB-6F8175C42A0AQ42675851-B5319C09-9B31-458C-9872-A721B3414C10Q47159765-63064334-2C58-4F1F-B87D-0CDD1E3A1FBBQ50682230-60CD9BEE-47E5-4243-A405-30A16684FAC7Q50985964-D256784C-5C3A-47F8-B82D-E0752518C6A1Q55033063-865C3825-A037-4CF2-9F35-0D855232A52FQ55498037-1F2EA1FB-D2B4-4AA7-AF85-D52725616EC8
P2860
Denosumab: a review of its use in postmenopausal women with osteoporosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Denosumab: a review of its use in postmenopausal women with osteoporosis.
@en
type
label
Denosumab: a review of its use in postmenopausal women with osteoporosis.
@en
prefLabel
Denosumab: a review of its use in postmenopausal women with osteoporosis.
@en
P2860
P1433
P1476
Denosumab: a review of its use in postmenopausal women with osteoporosis.
@en
P2860
P2888
P304
P356
10.1007/S40266-014-0191-3
P577
2014-07-01T00:00:00Z